HEADER TRANSCRIPTION 10-OCT-13 4CB7 TITLE STRUCTURE OF INFLUENZA A H5N1 PB2 CAP-BINDING DOMAIN WITH BOUND CAP TITLE 2 ANALOGUE (COMPOUND 8E) COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLYMERASE BASIC SUBUNIT 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CAP-BINDING DOMAIN, RESIDUES 318-483; COMPND 5 SYNONYM: POLYMERASE PB2 SUBUNIT; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: LOOP DELETION VARIANT SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS; SOURCE 3 ORGANISM_TAXID: 365107; SOURCE 4 STRAIN: A/DUCK/SHANTOU/4610/2003(H5N1); SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: CODONPLUS RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET-M11 KEYWDS TRANSCRIPTION, CAP-BINDING INHIBITORS EXPDTA X-RAY DIFFRACTION AUTHOR S.PAUTUS,P.SEHR,J.LEWIS,A.FORTUNE,A.WOLKERSTORFER,O.SZOLAR, AUTHOR 2 D.GULLIGAY,T.LUNARDI,J.L.DECOUT,S.CUSACK REVDAT 3 20-DEC-23 4CB7 1 REMARK REVDAT 2 25-DEC-13 4CB7 1 JRNL REVDAT 1 30-OCT-13 4CB7 0 JRNL AUTH S.PAUTUS,P.SEHR,J.LEWIS,A.FORTUNE,A.WOLKERSTORFER,O.SZOLAR, JRNL AUTH 2 D.GULLIGAY,T.LUNARDI,J.L.DECOUT,S.CUSACK JRNL TITL NEW 7-METHYL-GUANOSINE DERIVATIVES TARGETING THE INFLUENZA JRNL TITL 2 POLYMERASE PB2 CAP-BINDING DOMAIN JRNL REF J.MED.CHEM. V. 56 8915 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 24134208 JRNL DOI 10.1021/JM401369Y REMARK 2 REMARK 2 RESOLUTION. 1.85 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.85 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 3 NUMBER OF REFLECTIONS : 24506 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.173 REMARK 3 R VALUE (WORKING SET) : 0.171 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1313 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.85 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.90 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1813 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.79 REMARK 3 BIN R VALUE (WORKING SET) : 0.2210 REMARK 3 BIN FREE R VALUE SET COUNT : 82 REMARK 3 BIN FREE R VALUE : 0.3080 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2450 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 49 REMARK 3 SOLVENT ATOMS : 129 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.19000 REMARK 3 B22 (A**2) : 0.04000 REMARK 3 B33 (A**2) : 1.14000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.30000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.142 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.134 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.090 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.968 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.959 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.943 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2583 ; 0.013 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2573 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3476 ; 1.630 ; 1.982 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5913 ; 0.771 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 327 ; 5.952 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 109 ;31.276 ;23.119 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 492 ;14.352 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;12.936 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 397 ; 0.094 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2876 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 592 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. U VALUES REFINED INDIVIDUALLY REMARK 4 REMARK 4 4CB7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-OCT-13. REMARK 100 THE DEPOSITION ID IS D_1290058699. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9749 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25819 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.850 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 3.290 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.85 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.94 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 2.90 REMARK 200 R MERGE FOR SHELL (I) : 0.43000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2VQZ REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 40.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M AMMONIUM NITRATE, PH 6.3, 20 % REMARK 280 PEG 3350 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 54.09000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 317 REMARK 465 ARG A 318 REMARK 465 LYS A 478 REMARK 465 MET A 479 REMARK 465 GLY B 317 REMARK 465 ARG B 318 REMARK 465 ILE B 319 REMARK 465 SER B 320 REMARK 465 ASN B 419 REMARK 465 PHE B 420 REMARK 465 GLY B 421 REMARK 465 SER B 422 REMARK 465 MET B 479 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 2020 O HOH B 2045 1.91 REMARK 500 OE2 GLU B 391 O HOH B 2040 2.17 REMARK 500 O LYS B 412 NH1 ARG B 415 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 321 142.88 -171.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1478 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1479 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1480 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1479 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 41G B 1481 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4CB4 RELATED DB: PDB REMARK 900 STRUCTURE OF INFLUENZA A H5N1 PB2 CAP-BINDING DOMAIN WITH BOUND REMARK 900 M7GTP REMARK 900 RELATED ID: 4CB5 RELATED DB: PDB REMARK 900 STRUCTURE OF INFLUENZA A H5N1 PB2 CAP-BINDING DOMAIN WITH BOUND CAP REMARK 900 ANALOGUE (COMPOUND 8F) REMARK 900 RELATED ID: 4CB6 RELATED DB: PDB REMARK 900 STRUCTURE OF INFLUENZA A H5N1 PB2 CAP-BINDING DOMAIN WITH BOUND CAP REMARK 900 ANALOGUE (COMPOUND 11) REMARK 999 REMARK 999 SEQUENCE REMARK 999 EXTRA N-TERMINAL GLYCINE AFTER HIS-TAG CLEAVAGE LOOP REMARK 999 DELETION VARIANT 420-FVNRANQRLNP REPLACED BY 420-FGSGLNP DBREF 4CB7 A 318 479 UNP Q2LG68 Q2LG68_9INFA 318 483 DBREF 4CB7 B 318 479 UNP Q2LG68 Q2LG68_9INFA 318 483 SEQADV 4CB7 GLY A 317 UNP Q2LG68 EXPRESSION TAG SEQADV 4CB7 GLY A 421 UNP Q2LG68 VAL 421 ENGINEERED MUTATION SEQADV 4CB7 A UNP Q2LG68 ASN 422 DELETION SEQADV 4CB7 A UNP Q2LG68 ARG 423 DELETION SEQADV 4CB7 A UNP Q2LG68 ALA 424 DELETION SEQADV 4CB7 A UNP Q2LG68 ASN 425 DELETION SEQADV 4CB7 SER A 422 UNP Q2LG68 GLN 426 ENGINEERED MUTATION SEQADV 4CB7 GLY A 423 UNP Q2LG68 ARG 427 ENGINEERED MUTATION SEQADV 4CB7 GLY B 317 UNP Q2LG68 EXPRESSION TAG SEQADV 4CB7 GLY B 421 UNP Q2LG68 VAL 421 ENGINEERED MUTATION SEQADV 4CB7 B UNP Q2LG68 ASN 422 DELETION SEQADV 4CB7 B UNP Q2LG68 ARG 423 DELETION SEQADV 4CB7 B UNP Q2LG68 ALA 424 DELETION SEQADV 4CB7 B UNP Q2LG68 ASN 425 DELETION SEQADV 4CB7 SER B 422 UNP Q2LG68 GLN 426 ENGINEERED MUTATION SEQADV 4CB7 GLY B 423 UNP Q2LG68 ARG 427 ENGINEERED MUTATION SEQRES 1 A 163 GLY ARG ILE SER SER SER PHE SER PHE GLY GLY PHE THR SEQRES 2 A 163 PHE LYS ARG THR SER GLY SER SER VAL LYS LYS GLU GLU SEQRES 3 A 163 GLU VAL LEU THR GLY ASN LEU GLN THR LEU LYS ILE ARG SEQRES 4 A 163 VAL HIS GLU GLY TYR GLU GLU PHE THR MET VAL GLY ARG SEQRES 5 A 163 ARG ALA THR ALA ILE LEU ARG LYS ALA THR ARG ARG LEU SEQRES 6 A 163 ILE GLN LEU ILE VAL SER GLY ARG ASP GLU GLN SER ILE SEQRES 7 A 163 ALA GLU ALA ILE ILE VAL ALA MET VAL PHE SER GLN GLU SEQRES 8 A 163 ASP CYS MET ILE LYS ALA VAL ARG GLY ASP LEU ASN PHE SEQRES 9 A 163 GLY SER GLY LEU ASN PRO MET HIS GLN LEU LEU ARG HIS SEQRES 10 A 163 PHE GLN LYS ASP ALA LYS VAL LEU PHE GLN ASN TRP GLY SEQRES 11 A 163 ILE GLU PRO ILE ASP ASN VAL MET GLY MET ILE GLY ILE SEQRES 12 A 163 LEU PRO ASP MET THR PRO SER THR GLU MET SER LEU ARG SEQRES 13 A 163 GLY VAL ARG VAL SER LYS MET SEQRES 1 B 163 GLY ARG ILE SER SER SER PHE SER PHE GLY GLY PHE THR SEQRES 2 B 163 PHE LYS ARG THR SER GLY SER SER VAL LYS LYS GLU GLU SEQRES 3 B 163 GLU VAL LEU THR GLY ASN LEU GLN THR LEU LYS ILE ARG SEQRES 4 B 163 VAL HIS GLU GLY TYR GLU GLU PHE THR MET VAL GLY ARG SEQRES 5 B 163 ARG ALA THR ALA ILE LEU ARG LYS ALA THR ARG ARG LEU SEQRES 6 B 163 ILE GLN LEU ILE VAL SER GLY ARG ASP GLU GLN SER ILE SEQRES 7 B 163 ALA GLU ALA ILE ILE VAL ALA MET VAL PHE SER GLN GLU SEQRES 8 B 163 ASP CYS MET ILE LYS ALA VAL ARG GLY ASP LEU ASN PHE SEQRES 9 B 163 GLY SER GLY LEU ASN PRO MET HIS GLN LEU LEU ARG HIS SEQRES 10 B 163 PHE GLN LYS ASP ALA LYS VAL LEU PHE GLN ASN TRP GLY SEQRES 11 B 163 ILE GLU PRO ILE ASP ASN VAL MET GLY MET ILE GLY ILE SEQRES 12 B 163 LEU PRO ASP MET THR PRO SER THR GLU MET SER LEU ARG SEQRES 13 B 163 GLY VAL ARG VAL SER LYS MET HET GOL A1478 6 HET GOL A1479 6 HET GOL B1479 6 HET GOL B1480 6 HET 41G B1481 25 HETNAM GOL GLYCEROL HETNAM 41G 5-[2-(2-AZANYL-7-METHYL-6-OXIDANYLIDENE-1H-PURIN-9-IUM- HETNAM 2 41G 9-YL)ETHANOYL]-2-OXIDANYL-BENZOIC ACID HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 4(C3 H8 O3) FORMUL 7 41G C15 H14 N5 O5 1+ FORMUL 8 HOH *129(H2 O) HELIX 1 1 ASP A 390 GLN A 406 1 17 HELIX 2 2 GLU A 407 ALA A 413 1 7 HELIX 3 3 ASN A 425 ASP A 437 1 13 HELIX 4 4 ALA A 438 GLY A 446 1 9 HELIX 5 5 ASP B 390 GLN B 406 1 17 HELIX 6 6 GLU B 407 ALA B 413 1 7 HELIX 7 7 ASN B 425 ASP B 437 1 13 HELIX 8 8 ALA B 438 GLY B 446 1 9 SHEET 1 AA 6 SER A 321 PHE A 325 0 SHEET 2 AA 6 PHE A 328 GLY A 335 -1 O PHE A 328 N PHE A 325 SHEET 3 AA 6 GLU A 361 GLY A 367 -1 O GLU A 362 N THR A 333 SHEET 4 AA 6 ALA A 370 ALA A 377 -1 O ALA A 370 N GLY A 367 SHEET 5 AA 6 ARG A 380 GLY A 388 -1 O ARG A 380 N ALA A 377 SHEET 6 AA 6 VAL A 474 VAL A 476 1 O ARG A 475 N VAL A 386 SHEET 1 AB 2 VAL A 338 LEU A 345 0 SHEET 2 AB 2 THR A 351 GLU A 358 -1 O LEU A 352 N VAL A 344 SHEET 1 AC 2 ILE A 447 PRO A 449 0 SHEET 2 AC 2 MET A 469 LEU A 471 -1 O SER A 470 N GLU A 448 SHEET 1 AD 2 GLY A 458 ILE A 459 0 SHEET 2 AD 2 PRO A 465 SER A 466 -1 O SER A 466 N GLY A 458 SHEET 1 BA 8 SER B 322 PHE B 325 0 SHEET 2 BA 8 PHE B 328 GLY B 335 -1 O PHE B 328 N PHE B 325 SHEET 3 BA 8 GLU B 361 VAL B 366 -1 O GLU B 362 N THR B 333 SHEET 4 BA 8 ALA B 370 ALA B 377 -1 O ALA B 372 N MET B 365 SHEET 5 BA 8 ARG B 380 GLY B 388 -1 O ARG B 380 N ALA B 377 SHEET 6 BA 8 VAL B 474 SER B 477 1 O ARG B 475 N VAL B 386 SHEET 7 BA 8 MET B 456 ILE B 459 -1 O ILE B 457 N VAL B 476 SHEET 8 BA 8 PRO B 465 SER B 466 -1 O SER B 466 N GLY B 458 SHEET 1 BB 2 VAL B 338 LEU B 345 0 SHEET 2 BB 2 THR B 351 GLU B 358 -1 O LEU B 352 N VAL B 344 SHEET 1 BC 2 ILE B 447 PRO B 449 0 SHEET 2 BC 2 MET B 469 LEU B 471 -1 O SER B 470 N GLU B 448 SITE 1 AC1 7 SER A 321 PHE A 323 ARG A 332 SER A 337 SITE 2 AC1 7 HIS A 357 GLU A 361 PHE A 404 SITE 1 AC2 7 GLY B 327 PHE B 328 GLY B 367 ARG B 368 SITE 2 AC2 7 ARG B 369 HOH B2003 HOH B2041 SITE 1 AC3 5 VAL B 344 LEU B 345 ARG B 379 ASP B 408 SITE 2 AC3 5 LYS B 412 SITE 1 AC4 7 GLY A 327 PHE A 328 GLY A 367 ARG A 368 SITE 2 AC4 7 ARG A 369 ALA A 370 HOH A2034 SITE 1 AC5 15 SER A 336 SER B 321 PHE B 323 ARG B 332 SITE 2 AC5 15 SER B 337 LYS B 339 HIS B 357 GLU B 361 SITE 3 AC5 15 PHE B 363 LYS B 376 PHE B 404 PRO B 449 SITE 4 AC5 15 ILE B 450 ASP B 451 HOH B2065 CRYST1 36.940 108.180 39.050 90.00 91.08 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027071 0.000000 0.000510 0.00000 SCALE2 0.000000 0.009244 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025613 0.00000